Hibercell
PrivateLast Round
Debt
May 19, 2021
Total Funding Raised
$158.15M
Company Overview
HiberCell is a biotechnology company focused on developing innovative therapeutic agents that target adaptive stress pathways and immune modulation to combat cancer treatment resistance, relapse, and metastasis.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine, Healthcare Analytics
Business Model
B2B
Customer Profile
Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Hibercell Comps
Public and private peers based on sector, stage, and business model.
Hibercell Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Debt | May 19, 2021 | ||||
| Series B | May 19, 2021 | ||||
| Series A | Feb 7, 2019 |
Hibercell Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| New York City Economic Development Corporation | Series A |
| Hercules Capital | Debt, Series B |
| NYC Life Sciences Fund | Series A |
| Hillhouse Investment | Series A |
| Magnetic Ventures | Series B |
| Trinitas Capital Management | Series B |
| ARCH Venture Partners | Series B, Series A |
Hibercell Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Hibercell's valuation, stock price, and market status.
